Portfolio Holdings Detail for ISIN IE00B3VWM098
Stock Name / Fund iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc
Issuer Blackrock
Entity holding fund iShares VII Public Limited Company
Entity Type Umbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300Q7FFITMZ2PFZ28
ETF Ticker CUS1(GBX) LSE
ETF Ticker CUSS(USD) LSE
ETF Ticker SXRG(EUR) F
ETF Ticker CSUSS.MI(EUR) CXE
ETF Ticker CSUSSz(USD) CXE
ETF Ticker CUSS.LS(USD) CXE
ETF Ticker CSUSS(EUR) ETF Plus
ETF Ticker CUS1.L(GBP) LSE
ETF Ticker CUSS.L(GBP) LSE

Holdings detail for COGT

Stock Name	Cogent Biosciences Inc
Ticker	COGT(USD) NASDAQ
TYPE	Common Stock
Country	USA
ISIN	US19240Q2012

Show aggregate COGT holdings

News associated with COGT

Cogent Biosciences (NASDAQ:COGT) Price Target Raised to $20.00: Cogent Biosciences (NASDAQ:COGT – Get Free Report) had its price target lifted by equities researchers at Guggenheim from $17.00 to $20.00 in a research note issued on Monday, MarketBeat.com reports. The firm currently has a “buy” rating on the technology company’s stock. Guggenheim’s price objective indicates a potential upside of 63.53% from the stock’s previous […] - 2025-08-27 02:08:48
Arizona State Retirement System Has $123,000 Position in Cogent Biosciences, Inc. (NASDAQ:COGT): Arizona State Retirement System grew its stake in Cogent Biosciences, Inc. (NASDAQ:COGT – Free Report) by 18.0% during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 20,567 shares of the technology company’s stock after purchasing an additional 3,142 shares during the […] - 2025-07-24 04:38:50
Cogent Biosciences (NASDAQ:COGT) Price Target Raised to $22.00 at Citigroup: Cogent Biosciences (NASDAQ:COGT – Free Report) had its price objective boosted by Citigroup from $15.00 to $22.00 in a research note issued to investors on Friday morning,Benzinga reports. Citigroup currently has a buy rating on the technology company’s stock. Several other equities analysts have also recently commented on COGT. HC Wainwright boosted their target price […] - 2025-07-21 04:55:01
Analysts See 19% Gains Ahead For FHLC: Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-07-14 09:54:06
Cogent Biosciences (NASDAQ:COGT) Trading 9% Higher Following Analyst Upgrade: Cogent Biosciences, Inc. (NASDAQ:COGT – Get Free Report)’s share price traded up 9% during trading on Wednesday after JPMorgan Chase & Co. raised their price target on the stock from $25.00 to $29.00. JPMorgan Chase & Co. currently has an overweight rating on the stock. Cogent Biosciences traded as high as $10.12 and last traded […] - 2025-07-11 02:22:49
Cogent Biosciences (NASDAQ:COGT) Sees Large Volume Increase on Analyst Upgrade: Shares of Cogent Biosciences, Inc. (NASDAQ:COGT – Get Free Report) saw strong trading volume on Tuesday after HC Wainwright raised their price target on the stock from $12.00 to $22.00. HC Wainwright currently has a buy rating on the stock. 4,989,146 shares changed hands during mid-day trading, an increase of 236% from the previous session’s […] - 2025-07-10 02:52:43
Cogent Biosciences, Inc. (NASDAQ:COGT) Given Average Recommendation of “Moderate Buy” by Brokerages: Cogent Biosciences, Inc. (NASDAQ:COGT – Get Free Report) has received a consensus rating of “Moderate Buy” from the ten ratings firms that are covering the stock, MarketBeat.com reports. Three analysts have rated the stock with a hold recommendation, six have issued a buy recommendation and one has given a strong buy recommendation to the company. […] - 2025-07-08 05:26:50
Pre-Market Most Active for Jul 7, 2025 : TSLL, TSLA, TSLQ, COGT, BBAI, SQQQ, NVDA, HLN, CRCL, NIO, OSCR, QBTS: The NASDAQ 100 Pre-Market Indicator is down -99.52 to 22,767.45. The total Pre-Market volume is currently 171,325,842 shares traded.The following are the most active stocks for the pre-market session: Direxion Daily TSLA Bull 2X Shares (TSLL) is -1.4 at $10.13, with 43,244,717 s - 2025-07-07 09:29:58
Wedbush Reiterates “Neutral” Rating for Cogent Biosciences (NASDAQ:COGT): Cogent Biosciences (NASDAQ:COGT – Get Free Report)‘s stock had its “neutral” rating reissued by research analysts at Wedbush in a report issued on Monday,RTT News reports. They presently have a $10.00 target price on the technology company’s stock. Wedbush’s price objective would suggest a potential upside of 38.50% from the stock’s previous close. A number […] - 2025-07-02 02:56:48
Needham & Company LLC Reiterates Hold Rating for Cogent Biosciences (NASDAQ:COGT): Cogent Biosciences (NASDAQ:COGT – Get Free Report)‘s stock had its “hold” rating restated by equities research analysts at Needham & Company LLC in a note issued to investors on Tuesday,Benzinga reports. Several other research firms also recently commented on COGT. Scotiabank started coverage on Cogent Biosciences in a research note on Friday, March 7th. They […] - 2025-06-19 02:26:49
Cogent Biosciences, Inc. (NASDAQ:COGT) Stock Position Lessened by Wellington Management Group LLP: Wellington Management Group LLP decreased its position in shares of Cogent Biosciences, Inc. (NASDAQ:COGT – Free Report) by 16.8% during the 4th quarter, Holdings Channel.com reports. The firm owned 284,850 shares of the technology company’s stock after selling 57,473 shares during the quarter. Wellington Management Group LLP’s holdings in Cogent Biosciences were worth $2,222,000 at […] - 2025-06-06 05:34:49
Nuveen Asset Management LLC Has $2.44 Million Stock Holdings in Cogent Biosciences, Inc. (NASDAQ:COGT): Nuveen Asset Management LLC lessened its holdings in shares of Cogent Biosciences, Inc. (NASDAQ:COGT – Free Report) by 0.6% during the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 313,099 shares of the technology company’s stock after selling 1,896 shares during the quarter. Nuveen Asset Management LLC’s holdings in Cogent Biosciences were worth $2,442,000 at […] - 2025-06-03 04:58:48
Cogent Biosciences, Inc. (NASDAQ:COGT) Position Increased by ProShare Advisors LLC: ProShare Advisors LLC increased its stake in Cogent Biosciences, Inc. (NASDAQ:COGT – Free Report) by 30.5% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 31,074 shares of the technology company’s stock after purchasing an additional 7,267 shares during the period. […] - 2025-06-01 05:44:58
Cogent Biosciences, Inc. (NASDAQ:COGT) Given Consensus Rating of “Moderate Buy” by Analysts: Shares of Cogent Biosciences, Inc. (NASDAQ:COGT – Get Free Report) have been assigned a consensus recommendation of “Moderate Buy” from the eight brokerages that are currently covering the company, MarketBeat reports. Three analysts have rated the stock with a hold recommendation, four have assigned a buy recommendation and one has given a strong buy recommendation […] - 2025-05-26 05:29:06
HC Wainwright Has Lowered Expectations for Cogent Biosciences (NASDAQ:COGT) Stock Price: Cogent Biosciences (NASDAQ:COGT – Get Free Report) had its price target lowered by analysts at HC Wainwright from $14.00 to $12.00 in a research report issued to clients and investors on Tuesday,Benzinga reports. The brokerage currently has a “buy” rating on the technology company’s stock. HC Wainwright’s price target would indicate a potential upside of […] - 2025-05-22 03:12:43
30,300 Shares in Cogent Biosciences, Inc. (NASDAQ:COGT) Purchased by OMERS ADMINISTRATION Corp: OMERS ADMINISTRATION Corp purchased a new position in Cogent Biosciences, Inc. (NASDAQ:COGT – Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor purchased 30,300 shares of the technology company’s stock, valued at approximately $236,000. Several other hedge funds […] - 2025-05-21 05:26:52
D. E. Shaw & Co. Inc. Decreases Stock Holdings in Cogent Biosciences, Inc. (NASDAQ:COGT): D. E. Shaw & Co. Inc. lowered its position in Cogent Biosciences, Inc. (NASDAQ:COGT – Free Report) by 25.6% during the 4th quarter, HoldingsChannel reports. The fund owned 339,988 shares of the technology company’s stock after selling 117,240 shares during the period. D. E. Shaw & Co. Inc.’s holdings in Cogent Biosciences were worth $2,652,000 […] - 2025-05-20 04:57:06
Schonfeld Strategic Advisors LLC Takes $78,000 Position in Cogent Biosciences, Inc. (NASDAQ:COGT): Schonfeld Strategic Advisors LLC purchased a new stake in shares of Cogent Biosciences, Inc. (NASDAQ:COGT – Free Report) during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm purchased 10,000 shares of the technology company’s stock, valued at approximately $78,000. A number of […] - 2025-05-15 05:40:52
Dimensional Fund Advisors LP Sells 48,771 Shares of Cogent Biosciences, Inc. (NASDAQ:COGT): Dimensional Fund Advisors LP lessened its position in Cogent Biosciences, Inc. (NASDAQ:COGT – Free Report) by 6.2% in the fourth quarter, HoldingsChannel reports. The firm owned 743,652 shares of the technology company’s stock after selling 48,771 shares during the quarter. Dimensional Fund Advisors LP’s holdings in Cogent Biosciences were worth $5,800,000 as of its most […] - 2025-05-12 04:50:50
Cogent Biosciences Sees Unusually High Options Volume (NASDAQ:COGT): Cogent Biosciences, Inc. (NASDAQ:COGT – Get Free Report) was the recipient of unusually large options trading activity on Thursday. Investors purchased 20,016 call options on the company. This is an increase of 5,019% compared to the typical volume of 391 call options. Cogent Biosciences Stock Up 8.1 % Shares of NASDAQ:COGT opened at $5.63 on […] - 2025-05-02 02:09:01
Legal & General Group Plc Sells 2,304 Shares of Cogent Biosciences, Inc. (NASDAQ:COGT): Legal & General Group Plc cut its position in Cogent Biosciences, Inc. (NASDAQ:COGT – Free Report) by 3.2% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 69,541 shares of the technology company’s stock after selling 2,304 shares during […] - 2025-04-30 04:46:50
Cogent Biosciences, Inc. (NASDAQ:COGT) Receives $14.43 Consensus Target Price from Analysts: Cogent Biosciences, Inc. (NASDAQ:COGT – Get Free Report) has been given a consensus rating of “Moderate Buy” by the eight ratings firms that are covering the company, Marketbeat Ratings reports. Three research analysts have rated the stock with a hold recommendation, four have given a buy recommendation and one has assigned a strong buy recommendation […] - 2025-04-29 04:41:03
Alliancebernstein L.P. Buys 382,882 Shares of Cogent Biosciences, Inc. (NASDAQ:COGT): Alliancebernstein L.P. lifted its position in Cogent Biosciences, Inc. (NASDAQ:COGT – Free Report) by 466.6% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 464,942 shares of the technology company’s stock after acquiring an additional 382,882 shares during the quarter. Alliancebernstein […] - 2025-04-15 04:52:58
KLP Kapitalforvaltning AS Acquires Shares of 11,300 Cogent Biosciences, Inc. (NASDAQ:COGT): KLP Kapitalforvaltning AS bought a new stake in shares of Cogent Biosciences, Inc. (NASDAQ:COGT – Free Report) in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm bought 11,300 shares of the technology company’s stock, valued at approximately $88,000. Other hedge funds and other institutional investors […] - 2025-04-11 04:44:59
Cogent Biosciences, Inc. (NASDAQ:COGT) Receives Consensus Rating of “Moderate Buy” from Analysts: Shares of Cogent Biosciences, Inc. (NASDAQ:COGT – Get Free Report) have received an average rating of “Moderate Buy” from the eight brokerages that are presently covering the stock, Marketbeat.com reports. Three equities research analysts have rated the stock with a hold rating, four have assigned a buy rating and one has issued a strong buy […] - 2025-04-04 04:57:00
Cogent Biosciences, Inc. (NASDAQ:COGT) Stock Holdings Boosted by Intech Investment Management LLC: Intech Investment Management LLC boosted its position in shares of Cogent Biosciences, Inc. (NASDAQ:COGT – Free Report) by 99.3% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 56,657 shares of the technology company’s stock after buying an additional 28,233 shares during the quarter. […] - 2025-03-25 06:31:05
Cogent Biosciences, Inc. (NASDAQ:COGT) Shares Sold by AlphaQuest LLC: AlphaQuest LLC reduced its stake in Cogent Biosciences, Inc. (NASDAQ:COGT – Free Report) by 67.9% during the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 8,012 shares of the technology company’s stock after selling 16,970 shares during the quarter. AlphaQuest LLC’s holdings in Cogent Biosciences were […] - 2025-03-20 06:13:09
Cogent Biosciences, Inc. (NASDAQ:COGT) Given Consensus Rating of “Moderate Buy” by Analysts: Shares of Cogent Biosciences, Inc. (NASDAQ:COGT – Get Free Report) have earned a consensus recommendation of “Moderate Buy” from the seven research firms that are currently covering the firm, Marketbeat reports. Three analysts have rated the stock with a hold recommendation and four have issued a buy recommendation on the company. The average twelve-month target […] - 2025-03-10 05:10:47
Cogent Biosciences (NASDAQ:COGT) Now Covered by Scotiabank: Scotiabank assumed coverage on shares of Cogent Biosciences (NASDAQ:COGT – Free Report) in a report issued on Friday morning, Marketbeat Ratings reports. The brokerage issued a sector outperform rating and a $17.00 price objective on the technology company’s stock. COGT has been the subject of several other research reports. Wedbush reaffirmed a “neutral” rating and […] - 2025-03-10 03:50:48
New York State Common Retirement Fund Acquires 2,200 Shares of Cogent Biosciences, Inc. (NASDAQ:COGT): New York State Common Retirement Fund boosted its holdings in shares of Cogent Biosciences, Inc. (NASDAQ:COGT – Free Report) by 10.5% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 23,102 shares of the technology company’s stock after purchasing an additional 2,200 shares […] - 2025-03-06 08:19:23

iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc COGT holdings

Date	Number of COGT Shares Held	Base Market Value of COGT Shares	Local Market Value of COGT Shares	Change in COGT Shares Held	Change in COGT Base Value	Current Price per COGT Share Held	Previous Price per COGT Share Held
2025-09-26 (Friday)	30,449	USD 431,158	USD 431,158
2025-09-25 (Thursday)	30,449	USD 404,667	USD 404,667	0	USD 1,218	USD 13.29	USD 13.25
2025-09-24 (Wednesday)	30,449	USD 403,449	USD 403,449
2025-09-17 (Wednesday)	30,253	USD 373,927	USD 373,927	0	USD -5,446	USD 12.36	USD 12.54
2025-09-16 (Tuesday)	30,253	USD 379,373	USD 379,373
2025-09-12 (Friday)	30,057	USD 380,522	USD 380,522
2025-09-11 (Thursday)	30,057	USD 385,030	USD 385,030

Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of COGT by Blackrock for IE00B3VWM098

Show aggregate share trades of COGT

Date Action Quantity Market High Market Low Likely Trade Price Likely Trade Value (Profit/Loss) Average Price previous trades
2025-08-21 SELL -56 11.770* 7.78 Profit of 436 on sale
2025-07-31 BUY 168 11.420* 7.73
2025-06-30 SELL -112 7.180* 7.38 Profit of 827 on sale
2025-06-25 SELL -56 7.070* 7.39 Profit of 414 on sale
2025-06-20 SELL -112 7.230* 7.39 Profit of 828 on sale
2025-05-23 BUY 56 4.820* 7.58
2025-05-19 SELL -56 4.980* 7.66 Profit of 429 on sale
2025-05-15 SELL -168 4.770* 7.71 Profit of 1,296 on sale
2025-05-12 SELL -56 5.130* 7.79 Profit of 436 on sale
2025-05-09 SELL -56 4.810* 7.81 Profit of 438 on sale
2025-04-30 SELL -56 5.210* 7.99 Profit of 447 on sale
2025-04-24 SELL -112 4.510* 8.12 Profit of 909 on sale
2025-04-17 SELL -56 4.370* 8.32 Profit of 466 on sale
2025-04-15 SELL -168 4.870* 8.40 Profit of 1,411 on sale
2025-04-14 SELL -168 4.580* 8.44 Profit of 1,418 on sale
2025-04-09 SELL -224 4.460* 8.59 Profit of 1,923 on sale
2025-04-07 SELL -392 4.580* 8.68 Profit of 3,404 on sale
2025-04-04 SELL -560 4.770* 8.73 Profit of 4,889 on sale
2025-03-31 BUY 56 5.990* 8.84
2025-03-19 SELL -112 7.385* 9.04 Profit of 1,012 on sale
2025-03-14 SELL -336 7.140* 9.11 Profit of 3,062 on sale
2025-03-13 SELL -112 7.290* 9.14 Profit of 1,024 on sale
2025-03-12 SELL -1,904 7.590* 9.16 Profit of 17,444 on sale
2025-03-07 SELL -112 7.010* 9.26 Profit of 1,037 on sale
2025-03-06 SELL -168 7.410* 9.29 Profit of 1,560 on sale
2025-03-03 SELL -56 7.000* 9.38 Profit of 526 on sale
2025-02-28 SELL -58,315 7.530* 9.41 Profit of 549,007 on sale
2025-02-26 SELL -210 6.710* 9.50 Profit of 1,995 on sale
2025-02-25 SELL -630 6.990* 9.54 Profit of 6,013 on sale
2025-02-18 BUY 1,050 8.100* 9.70
2025-02-13 BUY 210 8.180* 9.79
2025-02-12 BUY 210 8.140* 9.83
2025-02-11 BUY 630 8.420* 9.86
2025-02-06 BUY 1,890 9.170* 9.92
2025-01-27 BUY 210 8.470* 10.08
2024-12-30 BUY 1,050 7.710* 10.31
2024-12-06 BUY 840 8.890* 10.40
2024-12-05 BUY 210 8.990* 10.45
2024-12-04 BUY 1,050 9.210* 10.49
2024-11-29 BUY 1,050 9.510* 10.63
2024-11-27 BUY 840 9.580* 10.72
2024-11-26 BUY 210 9.625* 10.77
2024-11-25 BUY 18,014 9.190* 10.84
2024-11-21 BUY 770 8.980* 11.03
2024-11-20 BUY 462 9.080* 11.14
2024-11-18 BUY 1,848 8.990* 11.40
2024-11-12 BUY 1,232 10.380* 11.47
2024-11-08 BUY 770 10.210* 11.56
2024-11-07 BUY 2,310 10.050* 11.68
2024-11-06 BUY 308 10.480* 11.78
2024-10-31 BUY 154 11.490* 12.04
Market high and low price is on the date.

Date	Action	Quantity	Likely Trade Price	Average Price previous trades
2025-08-21	SELL	-56	11.770*	7.78 Profit of 436 on sale
2025-07-31	BUY	168	11.420*	7.73
2025-06-30	SELL	-112	7.180*	7.38 Profit of 827 on sale
2025-06-25	SELL	-56	7.070*	7.39 Profit of 414 on sale
2025-06-20	SELL	-112	7.230*	7.39 Profit of 828 on sale
2025-05-23	BUY	56	4.820*	7.58
2025-05-19	SELL	-56	4.980*	7.66 Profit of 429 on sale
2025-05-15	SELL	-168	4.770*	7.71 Profit of 1,296 on sale
2025-05-12	SELL	-56	5.130*	7.79 Profit of 436 on sale
2025-05-09	SELL	-56	4.810*	7.81 Profit of 438 on sale
2025-04-30	SELL	-56	5.210*	7.99 Profit of 447 on sale
2025-04-24	SELL	-112	4.510*	8.12 Profit of 909 on sale
2025-04-17	SELL	-56	4.370*	8.32 Profit of 466 on sale
2025-04-15	SELL	-168	4.870*	8.40 Profit of 1,411 on sale
2025-04-14	SELL	-168	4.580*	8.44 Profit of 1,418 on sale
2025-04-09	SELL	-224	4.460*	8.59 Profit of 1,923 on sale
2025-04-07	SELL	-392	4.580*	8.68 Profit of 3,404 on sale
2025-04-04	SELL	-560	4.770*	8.73 Profit of 4,889 on sale
2025-03-31	BUY	56	5.990*	8.84
2025-03-19	SELL	-112	7.385*	9.04 Profit of 1,012 on sale
2025-03-14	SELL	-336	7.140*	9.11 Profit of 3,062 on sale
2025-03-13	SELL	-112	7.290*	9.14 Profit of 1,024 on sale
2025-03-12	SELL	-1,904	7.590*	9.16 Profit of 17,444 on sale
2025-03-07	SELL	-112	7.010*	9.26 Profit of 1,037 on sale
2025-03-06	SELL	-168	7.410*	9.29 Profit of 1,560 on sale
2025-03-03	SELL	-56	7.000*	9.38 Profit of 526 on sale
2025-02-28	SELL	-58,315	7.530*	9.41 Profit of 549,007 on sale
2025-02-26	SELL	-210	6.710*	9.50 Profit of 1,995 on sale
2025-02-25	SELL	-630	6.990*	9.54 Profit of 6,013 on sale
2025-02-18	BUY	1,050	8.100*	9.70
2025-02-13	BUY	210	8.180*	9.79
2025-02-12	BUY	210	8.140*	9.83
2025-02-11	BUY	630	8.420*	9.86
2025-02-06	BUY	1,890	9.170*	9.92
2025-01-27	BUY	210	8.470*	10.08
2024-12-30	BUY	1,050	7.710*	10.31
2024-12-06	BUY	840	8.890*	10.40
2024-12-05	BUY	210	8.990*	10.45
2024-12-04	BUY	1,050	9.210*	10.49
2024-11-29	BUY	1,050	9.510*	10.63
2024-11-27	BUY	840	9.580*	10.72
2024-11-26	BUY	210	9.625*	10.77
2024-11-25	BUY	18,014	9.190*	10.84
2024-11-21	BUY	770	8.980*	11.03
2024-11-20	BUY	462	9.080*	11.14
2024-11-18	BUY	1,848	8.990*	11.40
2024-11-12	BUY	1,232	10.380*	11.47
2024-11-08	BUY	770	10.210*	11.56
2024-11-07	BUY	2,310	10.050*	11.68
2024-11-06	BUY	308	10.480*	11.78
2024-10-31	BUY	154	11.490*	12.04

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of COGT

Date	Shorted Volume	Short Exempt Volume	Total Shares Traded	% Shorted
2025-09-19	178,710	0	374,744	47.7%
2025-09-18	144,303	0	492,031	29.3%
2025-09-17	204,285	1	726,102	28.1%
2025-09-16	150,691	0	462,672	32.6%
2025-09-15	123,353	9,124	300,516	41.0%
2025-09-12	450,700	3,878	931,716	48.4%
2025-09-11	772,950	0	1,176,197	65.7%
2025-09-10	261,353	0	456,012	57.3%
2025-09-09	511,477	0	964,761	53.0%
2025-09-08	209,439	0	470,138	44.5%
2025-09-05	465,988	0	673,243	69.2%
2025-09-04	181,762	0	430,780	42.2%
2025-09-03	473,022	0	1,810,674	26.1%
2025-09-02	176,868	2,239	441,974	40.0%
2025-08-29	87,706	0	418,644	21.0%
2025-08-28	148,192	0	494,102	30.0%
2025-08-27	139,566	0	227,000	61.5%
2025-08-26	98,499	0	159,127	61.9%
2025-08-25	116,374	55	228,986	50.8%
2025-08-22	116,232	0	299,050	38.9%
2025-08-21	43,039	100	186,987	23.0%
2025-08-20	128,443	146	178,217	72.1%
2025-08-19	156,176	100	290,001	53.9%
2025-08-18	350,319	0	521,654	67.2%
2025-08-15	150,305	0	224,409	67.0%
2025-08-14	177,013	0	478,177	37.0%
2025-08-13	221,392	123	621,407	35.6%
2025-08-12	173,664	0	323,917	53.6%
2025-08-11	112,167	0	242,980	46.2%
2025-08-08	214,099	0	398,838	53.7%
2025-08-07	286,806	0	721,705	39.7%
2025-08-06	199,883	19,134	622,043	32.1%
2025-08-05	359,248	0	998,340	36.0%
2025-08-04	172,949	11,386	344,270	50.2%
2025-08-01	229,951	794	427,500	53.8%
2025-07-31	232,840	127	882,862	26.4%
2025-07-30	364,907	5,808	619,895	58.9%
2025-07-29	136,763	40	415,525	32.9%
2025-07-28	152,949	0	381,681	40.1%
2025-07-25	297,157	0	584,570	50.8%
2025-07-24	193,704	400	733,305	26.4%
2025-07-23	452,121	619	1,363,605	33.2%
2025-07-22	658,945	0	1,703,582	38.7%
2025-07-21	363,053	62	886,644	40.9%
2025-07-18	475,602	5,000	1,732,913	27.4%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.

Stock Name / Fund	iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc
Issuer	Blackrock
Entity holding fund	iShares VII Public Limited Company
Entity Type	Umbrella investment company with variable capital and having segregated liability between its funds
Entity LEI	549300Q7FFITMZ2PFZ28
ETF Ticker	CUS1(GBX) LSE
ETF Ticker	CUSS(USD) LSE
ETF Ticker	SXRG(EUR) F
ETF Ticker	CSUSS.MI(EUR) CXE
ETF Ticker	CSUSSz(USD) CXE
ETF Ticker	CUSS.LS(USD) CXE
ETF Ticker	CSUSS(EUR) ETF Plus
ETF Ticker	CUS1.L(GBP) LSE
ETF Ticker	CUSS.L(GBP) LSE